Skip to content

The study of risk factors on frailty and sarcopenia in elderly diabetic patients

The study of risk factors on frailty and sarcopenia in elderly diabetic patients - The study of frailty in elderly diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031357
Enrollment
140
Registered
2018-02-18
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Sponsors

Muta Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese elderly patients( aged 65 years or older) receiving treatment for type 2 diabetes in Muta Hospital.

Exclusion criteria

Exclusion criteria: Patients under 65 years of age or without type 2 diabetes.

Design outcomes

Primary

MeasureTime frame
We will evaluate which factors of the evaluation items such as blood DHEA-S, cortisol, cortisol / DHEAS ratio, other blood collection results, physical function, cognitive function, arteriosclerosis and osteoporosis etc are related to frailty and sarcopenia.

Countries

Japan

Contacts

Public ContactToshihiko Yanase

Fukuoka University Hospital Department of Endocrinology and Diabetes Mellitus

tyanase@fukuoka-u.ac.jp092-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026